Physician profile
Lois E Smith
NPI 1639269616
$40,344.26
in general payments reported to CMS, 2019-2025
3 companies · $7,880 in 2025
The $7,880 reported for 2025 was more than what 95% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,252 · 2020: $5,000 · 2021: $5,000 · 2022: $5,000 · 2023: $5,213 · 2024: $5,000 · 2025: $7,880.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Consulting Fee: $2,880 · Food and Beverage: $213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,000.00 |
| Consulting Fee | $2,880.00 |
| Food and Beverage | $212.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Research LLC | $35,000.00 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $5,069.77 | 2019-2025 | |
| Alcon Vision LLC | $274.49 | 2019-2023 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lois Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.